Skip to content
VitroScreen
  • About
  • Non Clinical
    • Therapeutic areas
    • Microbiome Research Unit
    • Medical Devices
    • Histo-Morphology Platform
  • VitroScreenORA®
  • Regulatory & Consultancy
    • GLP Certified Assays
    • OECD TG 428
    • Sensitization potential by Alternatives
    • Consultancy Unit
  • News
  • Publications
  • Contacts
VitroScreen
  • About
  • Non Clinical
    • Therapeutic areas
    • Microbiome Research Unit
    • Medical Devices
    • Histo-Morphology Platform
  • VitroScreenORA®
  • Regulatory & Consultancy
    • GLP Certified Assays
    • OECD TG 428
    • Sensitization potential by Alternatives
    • Consultancy Unit
  • News
  • Publications
  • Contacts
VitroScreen
  • About
  • Non Clinical
    • Therapeutic areas
    • Microbiome Research Unit
    • Medical Devices
    • Histo-Morphology Platform
  • VitroScreenORA®
  • Regulatory & Consultancy
    • GLP Certified Assays
    • OECD TG 428
    • Sensitization potential by Alternatives
    • Consultancy Unit
  • News
  • Publications
  • Contacts

Month: April 2022

  1. Home
  2. Archives: April 2022

FOCUS 02.22
VitroScreen Advanced
Wound Healing Model
April 2022

In April 2022 the project EUROSTARS E! 113238 – LYSE-EFEKT ended: it has been an enriching, multidisciplinary three-years long experience…

Continue reading
VitroScreen

VitroScreen s.r.l.

Testing Facility and Headquarter:
via Mosè Bianchi, 103
20149 Milano – Italy


Cap. Soc € 15.000
P. IVA 13454040158
REA MI n. 1653696

Contact

Ph.: 39-02-89077608
Email: infos@vitroscreen.com
Pec: vitroscreen@pec.retesi.it

Linkedin-in

© Copyright 2025| VitroScreen s.r.l. | Privacy Policy | Cookies

VitroScreen part of the SenzaGen Group

© Copyright 2025| VitroScreen s.r.l. Privacy Policy | Cookies

VitroScreen part of the SenzaGen Group